Additional considerations include: Dietary quality changes during weight loss programmes Increased urinary magnesium excretion in poorly controlled diabetes (though GLP-1 therapy typically improves glycaemic control) Concurrent medications that may affect magnesium status, such as proton pump inhibitors or diuretics It is important to note that routine magnesium monitoring is not currently recommended in NICE guidance (NG28) for patients on GLP-1 therapy
328 Marcovecchio, M
Detailed Side-Effect Tracking and Journaling This tool features a robust side-effect tracker and journal, enabling users to log symptoms like nausea, constipation, and fatigue, along with their timing and severity
For men struggling with low testosterone, obesity, and sexual dysfunction, this could open the door to more effective, sustainable treatment options
Lay out your supplies: semaglutide vial, bacteriostatic water vial, insulin syringe (1 mL), alcohol swabs